Hidenao Sasaki

ORCID: 0000-0002-5164-942X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genetic Neurodegenerative Diseases
  • Parkinson's Disease Mechanisms and Treatments
  • Mitochondrial Function and Pathology
  • Neurological disorders and treatments
  • Amyotrophic Lateral Sclerosis Research
  • Multiple Sclerosis Research Studies
  • Neurological diseases and metabolism
  • Peripheral Neuropathies and Disorders
  • RNA regulation and disease
  • Autoimmune Neurological Disorders and Treatments
  • Hereditary Neurological Disorders
  • T-cell and B-cell Immunology
  • Alzheimer's disease research and treatments
  • Botulinum Toxin and Related Neurological Disorders
  • Neurogenetic and Muscular Disorders Research
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Metabolism and Genetic Disorders
  • MicroRNA in disease regulation
  • RNA Research and Splicing
  • Neurological and metabolic disorders
  • Prion Diseases and Protein Misfolding
  • Myasthenia Gravis and Thymoma
  • Ubiquitin and proteasome pathways
  • DNA Repair Mechanisms
  • Sarcoidosis and Beryllium Toxicity Research

Hokkaido University
2015-2024

Hakodate Central General Hospital
2020-2024

Chiba University Hospital
2024

Sasaki Institute
2017-2018

Hokkaido University Hospital
2008-2017

Neurology, Inc
2011

Sanin Rosai Hospital
2008

Nagasaki University
2007

University of Maryland, College Park
2007

T4tech (Italy)
2007

Multiple-system atrophy is an intractable neurodegenerative disease characterized by autonomic failure in addition to various combinations of parkinsonism, cerebellar ataxia, and pyramidal dysfunction. Although multiple-system widely considered be a nongenetic disorder, we previously identified multiplex families with this disease, which indicates the involvement genetic components.

10.1056/nejmoa1212115 article EN New England Journal of Medicine 2013-06-12

Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease, which leads to the loss of upper and lower motor neurons, with currently unknown etiology. Specific biomarkers could help in early detection diagnosis, also act as indicators disease progression therapy effectiveness. MicroRNAs (miRNAs) are small (18-25 nucleotides), single-stranded non-coding RNA molecules that play important regulatory roles animals plants by targeting mRNAs for cleavage or translational repression,...

10.1186/s13041-015-0161-7 article EN cc-by Molecular Brain 2015-10-24

Glucocerebrosidase gene (GBA) variants that cause Gaucher disease are associated with Parkinson (PD) and dementia Lewy bodies (DLB). To investigate the role of GBA in multiple system atrophy (MSA), we analyzed a large case-control series.We sequenced coding regions flanking splice sites 969 MSA patients (574 Japanese, 223 European, 172 North American) 1509 control subjects (900 315 294 American). We focused solely on Gaucher-disease-causing variants.In Japanese series, found nine carriers...

10.1002/acn3.185 article EN cc-by-nc-nd Annals of Clinical and Translational Neurology 2015-02-28

Proximal tremors are often refractory to nucleus ventrointermedius thalami thalamotomy. Subthalamotomy has been suggested be effective for treatment of tremor, although this procedure is associated with considerable adverse effects, and rarely considered a suitable modality. The authors demonstrate the efficacy safety subthalamic deep brain stimulation in two patients, one severe, proximal essential tremor dystonia.

10.1212/wnl.55.1.114 article EN Neurology 2000-07-12

Abstract We measured the concentrations of glutamate, asparate, and γ‐aminobutyrate (GABA) in cortical subcortical areas by an enzymatic fluorometric method 9 patients with histologically verified Alzheimer's disease senile dementia Alzheimer type (AD/SDAT), 10 age‐matched normal control subjects. When compared controls, concentration glutamate AD/SDAT brains was significantly reduced. The aspartate GABA were also reduced several areas, but magnitude reduction less than that glutamate. This...

10.1002/ana.410190307 article EN Annals of Neurology 1986-03-01

MicroRNAs (miRNAs) are endogenous small (18–25 nt), single-stranded, non-coding RNAs that play key roles in post-transcriptional gene expression regulation. The profiles of miRNAs biofluids and tissues change various diseases. Multiple system atrophy (MSA) Parkinson's disease (PD) both categorized as α-synucleinopathies often present with similar clinical manifestations. This study aimed to identify differently expressed plasma samples PD patients, MSA healthy controls. We used microarray...

10.1186/s13041-019-0471-2 article EN cc-by Molecular Brain 2019-05-14

We previously discovered spinocerebellar ataxia type 14 (SCA14) in a single Japanese family with an autosomal dominant neurodegenerative disorder characterized by cerebellar and intermittent axial myoclonus. The latter manifestation is selectively observed patients early onset. mapped the locus to chromosome 19q13.4-qter, but etiologic gene was not known. Recently, mutation protein kinase C gamma (PRKCG) identified US of English Dutch ancestry SCA whose disease region overlapping that SCA14...

10.1001/archneur.60.12.1749 article EN Archives of Neurology 2003-12-01

A decrease in intracellular glutathione content may be related to the primary event Parkinson's disease, so increasing level have a therapeutic benefit. The biologically active form of vitamin D, 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] has been recently reported enhance concentration central nervous system. Exposing rat cultured mesencephalic neurons for 24 hr mixture L-buthionine sulfoximine (BSO) and 1-methyl-4-phenylpyridium ions (MPP+) resulted relatively selective damage dopaminergic...

10.1002/1097-4547(20001101)62:3<374::aid-jnr7>3.0.co;2-7 article EN Journal of Neuroscience Research 2000-01-01

Patients with Parkinson's disease often have urine storage symptoms, such as urinary urgency, frequency and incontinence, which are induced by detrusor overactivity. However, little is known of the mechanisms inducing overactivity in this disease. We previously examined human brain response to bladder filling healthy male volunteers using positron emission tomography. hypothesized that activation patterns would be different patients disease.Nine were catheterized via urethra for intravesical...

10.1016/s0022-5347(05)00324-1 article EN The Journal of Urology 2006-02-10

Machado-Joseph disease (MJD) is an autosomal dominant multisystem neurodegenerative disorder caused by unstable expansion of a CAG repeat in the MJD1 gene at 14q432.1. To identify elements affecting intergenerational instability repeat, we investigated whether CGG/GGG polymorphism 3′ end affects repeat. The [expanded (CAG)n-CGG]/[normal (CAG)n-GGG] haplotypes were found to result significantly greater compared (CAG)n-CGG] or (CAG)nGGG]/[normal haplotypes. Multiple stepwise logistic...

10.1093/hmg/5.7.923 article EN Human Molecular Genetics 1996-07-01
Coming Soon ...